By rehabilitating donor organs deemed unfit for transplant, the xenogeneic cross-circulation platform holds potential to eliminate transplant waitlist mortality.

通过恢复被认为不适合移植的供体器官，异种交叉循环平台具有消除移植候补名单死亡率的潜力。

NEW YORK, May 8, 2024 /PRNewswire/ -- Xylyx Bio, a regenerative medicine company developing innovative solutions for tissue and organ repair, today announced entry into an exclusive license agreement with Vanderbilt University for the rights to a xenogeneic cross-circulation platform that restores damaged donor organs to transplant condition..

2024年5月8日，纽约/PRNewswire/--Xylyx Bio是一家开发组织和器官修复创新解决方案的再生医学公司，今天宣布与范德比尔特大学签订独家许可协议，获得异种交叉循环平台的权利，该平台可将受损的供体器官恢复到移植状态。。

The donor organ shortage remains dire: Every 8 minutes another person is added to the U.S. transplant waitlist, and 17 people die each day waiting to receive an organ. Despite this pressing need, the majority of donor organs are not utilized for transplant, often due to acute reversible conditions. Salvaging rehabilitated donor organs can significantly increase the number of organs available for transplantation..

供体器官短缺仍然严峻：每8分钟就会有另一个人加入美国移植候补名单，每天有17人在等待器官移植时死亡。尽管有这种迫切的需求，但大多数供体器官通常由于急性可逆性疾病而未被用于移植。抢救康复的供体器官可以显着增加可用于移植的器官数量。。

'Our technology provides the systemic physiologic support and homeostatic regulation needed to rehabilitate and salvage donor organs that are not being utilized for transplant. Our team has demonstrated successful rehabilitation of donor lungs and livers, and we are thrilled to accelerate the path to patients,' said Matthew Bacchetta, MD, MBA, FACS, Professor of Cardiac and Thoracic Surgery and Biomedical Engineering, Director of the Laboratory for Organ Regeneration, Recovery, and Replacement, and Medical Director of Lung Transplant at Vanderbilt University Medical Center..

“我们的技术提供了恢复和挽救不用于移植的供体器官所需的全身生理支持和体内平衡调节。我们的团队已经证明了供体肺和肝脏的成功康复，我们很高兴能够加快通往患者的道路，”Matthew Bacchetta，医学博士，MBA，FACS，心胸外科和生物医学工程教授，器官再生，恢复和替代实验室主任，范德比尔特大学医学中心肺移植医学主任说道。。

'This platform represents a breakthrough in the organ transplant field and is a key addition to Xylyx Bio's portfolio of regenerative technologies,' said Andrea Nye, President and CEO of Xylyx Bio. 'We are proud to collaborate with Dr. Bacchetta and Vanderbilt University and are committed to our shared mission to advance the development of this groundbreaking technology for those awaiting a life-saving donor organ.'.

“这个平台代表了器官移植领域的一个突破，是Xylyx Bio再生技术组合的一个关键补充，”Xylyx Bio总裁兼首席执行官安德里亚·奈（Andrea Nye）说。“我们很自豪能与巴切塔博士和范德比尔特大学合作，并致力于我们的共同使命，为那些等待救生器官的人推进这项开创性技术的发展。”。

About Xylyx Bio: Xylyx Bio is a regenerative medicine company developing innovative approaches for tissue repair and regeneration. Xylyx Bio's mission is to eliminate transplant waitlist mortality. Robust pipeline development of Xylyx Bio's organ rehabilitation platform includes lead programs for donor lungs and donor livers and pre-clinical programs for kidneys and hearts.

关于Xylyx Bio：Xylyx Bio是一家再生医学公司，开发组织修复和再生的创新方法。Xylyx Bio的使命是消除移植候补死亡率。Xylyx Bio器官康复平台的强大管道开发包括供体肺和供体肝的主导项目以及肾脏和心脏的临床前项目。

To learn more, visit xylyxbio.com..

要了解更多信息，请访问xylyxbio.com。。

About Vanderbilt University: Vanderbilt University is globally renowned for its transformative education and research. Vanderbilt University Medical Center is the largest comprehensive research, teaching, and patient care health system in the Mid-South region, with the highest-ranked adult and children's hospitals in the Southeast by U.S.

关于范德比尔特大学：范德比尔特大学以其变革性的教育和研究而闻名全球。范德比尔特大学医学中心是中南地区最大的综合研究、教学和病人护理保健系统，拥有美国东南部排名最高的成人和儿童医院。

News & World Report..

新闻与世界报道。。

Contact

联系人

Andrea Nye

安德莉雅·妮尔

Xylyx Bio, Inc.

Xylyx生物公司。

andrea@xylyxbio.com

andrea@xylyxbio.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/xylyx-bio-announces-exclusive-license-agreement-with-vanderbilt-university-for-donor-organ-rehabilitation-asset-302139198.html

查看原始内容以下载多媒体：https://www.prnewswire.com/news-releases/xylyx-bio-announces-exclusive-license-agreement-with-vanderbilt-university-for-donor-organ-rehabilitation-asset-302139198.html

SOURCE Xylyx Bio, Inc.

来源：Xylyx生物公司。